Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Primary Dysautonomias × enzalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Prostatic Neoplasms, Castration-Resistant 2 Seizures 1 Prostate Cancer Metastatic 1 Primary Dysautonomias 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Kidney Diseases 1 Hypertension 1 Dementia 1 Cognitive Dysfunction 1

Interventions

enzalutamide 1 bicalutamide 1 Receptors, Androgen 1 Leuprolide 1 Goserelin 1 Flutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05700903 2026-03-02

ARCH

University of Colorado, Denver

Phase 4 Completed

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡